Skip to main content

GER and Helicobacter pylori

  • Chapter
  • First Online:
Gastroesophageal Reflux in Children
  • 358 Accesses

Abstract

Helicobacter pylori (H. pylori) infection has been shown to affect the severity and course of gastroesophageal reflux disease (GERD). In this chapter, we have updated these complex relationships based on recent developments in children’s studies, taking into account findings from studies in adults.

The effect of H. pylori on GERD differs according to the anatomical location of H. pylori infection (antrum, corpus, or pangastritis). The type of gastritis is also very important in the course of reflux esophagitis (acute, chronic, atrophic). H. pylori-associated gastritis in the corpus causes hypoacidity while antral gastritis causes hyperacidity. During childhood, H. pylori is associated with antral predominant gastritis and duodenal ulcers.

Gastrin is affected by the gastric localization of H. pylori infection, atrophic changes, and acute/chronic nature. In antral gastritis, hypergastrinemia occurs during the destruction of somatostatin-secreting cells during infection and it triggers acid production, and hyperacidity leads to the development or progression of GER and erosive esophagitis. In cases of antral gastritis that causes hyperacidity, reflux esophagitis may improve after H. pylori is eradicated. Chronic gastritis can lead to atrophic gastritis. Atrophic gastritis causes hypoacidity due to cell damage. In this case, GERD manifestations are provoked by the eradication of H. pylori. Histological studies have shown that atrophic gastritis is rare in children.

The determining factors that trigger H. pylori-related GERD are the location of gastritis in both children and adults, CagA/VacA positivity, and substances released from the stomach which lead to transient lower esophageal sphincter relaxations. Pangastritis causing gastric atrophy is associated with CagA strains and its protective effect against GERD has been demonstrated in corpus gastritis. H. pylori infection with CagA strains is associated with less severe reflux esophagitis in children. But, antral nodularity was found more frequently in CagA-positive patients. VacA, s1b positivity was associated with a lower frequency of esophagitis rate in children. Further studies are required to explain this complex relationship in childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BapA:

Blood group antigen-binding adhesin A

BE:

Barrett’s esophagus

BMI:

Body mass index

CagA:

Cytotoxin-associated gene A

DupA:

Duodenal ulcer promoting gene A protein

EAC:

Esophageal adenocarcinoma

GERD:

Gastroesophageal Reflux Disease

H. pylori :

Helicobacter pylori

HpSA:

H. pylori stool antigen

IL:

Interleukin

NO:

Nitric oxide

OipA:

Outer inflammatory protein

OMPs:

Outer membrane proteins

PGs:

Pepsinogens

PPIs:

Proton pump inhibitors

RE:

Reflux Esophagitis

SabA:

Sialic acid-binding adhesin

TLESR:

Transient lower esophageal sphincter relaxations

VacA:

Vacuolating cytotoxin A

References

  1. Liu L, Gao H, Wang H, et al. Comparison of esophageal function tests to investigate the effect of helicobacter pylori infection on Gastroesophageal Reflux Disease (GERD). Med Sci Monit. 2018;24:4791–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Jones NL, Koletzko S, Goodman K, et al. ESPGHAN, NASPGHAN. Joint ESPGHAN/NASPGHAN guidelines for the management of helicobacter pylori in children and adolescents (update 2016). J Pediatr Gastroenterol Nutr. 2017;64(6):991–1003.

    Article  PubMed  Google Scholar 

  3. Aguilera Matos I, Diaz Oliva SE, Escobedo AA, Villa Jiménez OM, Velazco Villaurrutia YDC. Helicobacter pylori infection in children. BMJ Paediatr Open. 2020;4(1):e000679.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Yucel O. Interactions between Helicobacter pylori and gastroesophageal reflux disease. Esophagus. 2019;16(1):52–62.

    Article  PubMed  Google Scholar 

  5. Okuda M, Mabe K, Lin Y, et al. Rapid urine antibody test for Helicobacter pylori infection in adolescents. Pediatr Int. 2017;59:798–802.

    Article  CAS  PubMed  Google Scholar 

  6. Scida S, Russo M, Miraglia C, et al. Relationship between Helicobacter pylori infection and GERD. Acta Biomed. 2018;89(8-S):40–3.

    CAS  PubMed  Google Scholar 

  7. Savarino E, de Bortoli N, De Cassan C, et al. The natural history of gastro-esophageal reflux disease: a comprehensive review. Dis Esop. 2017;30:1–9.

    CAS  Google Scholar 

  8. Doulberis M, Papaefthymiou A, Polyzos SA, et al. Helicobacter pylori, sleeve Gastrectomy, and gastroesophageal reflux disease: is there a relation? Obes Surg. 2021;31(4):1839–40.

    Article  PubMed  Google Scholar 

  9. Kountouras J, Doulberis M, Papaefthymiou A, et al. A perspective on risk factors for esophageal adenocarcinoma: emphasis on helicobacter pylori infection. Ann N Y Acad Sci. 2019;1452:12–7.

    Article  PubMed  Google Scholar 

  10. El Serag HB, Sonnenberg A, Jamal MM, et al. Corpus gastritis is protective against reflux esophagitis. Gut. 1999;45:181–5.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis. Am J Gastroenterol. 1999;94:3268–72.

    Article  Google Scholar 

  12. Lupu VV, Ignat A, Ciubotariu G, Ciubară A, Moscalu M, Burlea M. Helicobacter pylori infection and gastroesophageal reflux in children. Dis Esophagus. 2016;29:1007–12.

    Article  CAS  PubMed  Google Scholar 

  13. Ristic N, Milovanovic I, Radusinovic M, et al. The comparative analyses of different diagnostic approaches in detection of gastroesophageal reflux disease in children. PLoS One. 2017;12(11):e0187081.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Liu Y-W, Wu J-F, Chen H-L, et al. The correlation between endoscopic reflux esophagitis and combined multichannel intraluminal impedance-pH monitoring in children. Pediatr Neonatol. 2016;57:385–9.

    Article  PubMed  Google Scholar 

  15. Schwizer W, Fox M. Helicobacter pylori and gastroesophageal reflux disease: a complex organism in a complex host. J Pediatr Gastroenterol Nutr. 2004;38:12–5.

    Article  PubMed  Google Scholar 

  16. Kalach N, Bontems P, Raymond J. Helicobacter pylori infection in children. Helicobacter. 2017;22(Suppl. 1):e12414.

    Article  Google Scholar 

  17. Yang HR. Updates on the diagnosis of Helicobacter pylori infection in children: what are the differences between adults and children? Pediatr Gastroenterol Hepatol Nutr. 2016;19:96–103.

    Article  PubMed  PubMed Central  Google Scholar 

  18. George S, Mamani N, Lucero Y, et al. Detection of Helicobacter pylori by real-time PCR for 16s rRNA in stools of noninfected healthy children, using ELISA antigen stool test as the gold standard. Helicobacter. 2016;21:606–12.

    Article  CAS  PubMed  Google Scholar 

  19. Cam S. Risk of gastric cancer in children with Helicobacter pylori infection. Asian Pac J Cancer Prev. 2014;15(22):9905–8.

    Article  PubMed  Google Scholar 

  20. Yu Y, Su L, Wang X, et al. Association between Helicobacter pylori infection and pathological changes in the gastric mucosa in Chinese children. Intern Med. 2014;53:83–8.

    Article  PubMed  Google Scholar 

  21. Koca T, Serdaroglu F, Dereci S, Akcam M. Peptic ulcers and erosions in children at a pediatric unit in Turkey. Indian Pediatr. 2016;53:692–4.

    Article  PubMed  Google Scholar 

  22. Eren M, Colak Ö, Işıksoy S, Yavuz A. Effect of H. pylori infection on gastrin, ghrelin, motilin, and gastroesophageal reflux. Turk J Gastroenterol. 2015;26:367–72.

    Article  PubMed  Google Scholar 

  23. Thor PJ, Blaut U. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease. J Physiol Pharmacol. 2006;57:81–90.

    PubMed  Google Scholar 

  24. Zullo A, Hassan C, Repici A, Bruzzese V. Helicobacter pylori eradication and reflux disease onset: did gastric acid get “crazy”? World J Gastroenterol. 2013;19:786–9.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Hoepler W, Hammer K, Hammer J. Gastric phenotype in children with Helicobacter pylori infection undergoing upper endoscopy. Scand J Gastroenterol. 2011;46:293–8.

    Article  PubMed  Google Scholar 

  26. Langner C, Schneider NI, Plieschnegger W, et al. Cardiac mucosa at the gastro-oesophageal junction: indicator of gastrooesophageal reflux disease? Data from a prospective central European multicentre study on histological and endoscopic diagnosis of oesophagitis (histoGERD trial). Histopathology. 2014;65:81–9.

    Article  PubMed  Google Scholar 

  27. Carvalho MA, Machado NC, Ortolan EV, Rodrigues MA. Upper gastrointestinal histopathological findings in children and adolescents with nonulcer dyspepsia with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2012;55:523–9.

    Article  PubMed  Google Scholar 

  28. Bedoya A, Garay J, Sanzón F, et al. Histopathology of gastritis in Helicobacter pylori-infected children from populations at high and low gastric cancer risk. Hum Pathol. 2003;34:206–13.

    Article  PubMed  Google Scholar 

  29. Guiraldes E, Peña A, Duarte I, et al. Nature and extent of gastric lesions in symptomatic Chilean children with Helicobacter pylori associated gastritis. Acta Paediatr. 2002;91:39–44.

    Article  CAS  PubMed  Google Scholar 

  30. Kato S, Nishino Y, Ozawa K, et al. The prevalence of Helicobacter pylori in Japanese children with gastritis or peptic ulcer disease. J Gastroenterol. 2004;39:734–8.

    Article  PubMed  Google Scholar 

  31. Macarthur C, Saunders N, Feldman W. Helicobacter pylori, gastroduodenal disease, and recurrent abdominal pain in children. JAMA. 1995;273:729–34.

    Article  CAS  PubMed  Google Scholar 

  32. Gold BD. Helicobacter pylori infection in children. Curr Probl Pediatr Adolesc Health Care. 2001;31:247–66.

    Article  CAS  PubMed  Google Scholar 

  33. Sherman P, Czinn S, Drumm B, et al. Helicobacter pylori infection in children and adolescents: working group report of the first world congress of pediatric gastroenterology, hepatology, and nutrition. J Pediatr Gastroenterol Nutr. 2002;35(Suppl 2):S128–33.

    Article  PubMed  Google Scholar 

  34. Blecker U. Helicobacter pylori-associated gastroduodenal disease in childhood. South Med J. 1997;90:570–6.15.

    CAS  PubMed  Google Scholar 

  35. Hackelsberger A, Gunther T, Schultze V, et al. Role of aging in the expression of Helicobacter pylori gastritis in the antrum, corpus, and cardia. Scand J Gastroenterol. 1999;34:138–43.

    Article  CAS  PubMed  Google Scholar 

  36. Xinias I, Maris T, Mavroudi A, Panteliadis C, Vandenplas Y. Helicobacter pylori infection has no impact on manometric and pH-metric findings in adolescents and young adults with gastroesophageal reflux and antral gastritis: eradication results to no significant clinical improvement. Pediatr Rep. 2013;5:e3.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Daugule I, Rowland M. Helicobacter pylori infection in children. Helicobacter. 2008;13(Suppl 1):41–6.

    Article  CAS  PubMed  Google Scholar 

  38. Hojsak I, Ivković L, Trbojević T, et al. The role of combined 24-h multichannel intraluminal impedance-pH monitoring in the evaluation of children with gastrointestinal symptoms suggesting gastro-esophageal reflux disease. Neurogastroenterol Motil Off J Eur Gastrointest Motil Soc. 2016;28:1488–93.

    Article  CAS  Google Scholar 

  39. Dent J, Brun J, Fendrick A, et al. An evidence-based appraisal of reflux disease management--the Genval workshop report. Gut. 1999;44(Suppl 2):S1–16.

    Article  PubMed Central  Google Scholar 

  40. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009;49:498–547.

    Article  PubMed  Google Scholar 

  41. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Moon A, Solomon A, Beneck D, Cunningham-Rundles S. Positive association between Helicobacter pylori and gastroesophageal reflux disease in children. J Pediatr Gastroenterol Nutr. 2009;49:283–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Pilic D, Hankel S, Koerner-Rettberg C, Hamelmann E, Schmidt-Choudhury A. The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease. Scand J Gastroenterol. 2013;48:785–93.

    Article  PubMed  Google Scholar 

  44. Salvatore S, Hauser B, Vandemaele K, Novario R, Vandenplas Y. Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology? J Pediatr Gastroenterol Nutr. 2005;40:210–5.

    Article  PubMed  Google Scholar 

  45. Salvatore S, Hauser B, Devreker T, et al. Esophageal impedance and esophagitis in children: any correlation? J Pediatr Gastroenterol Nutr. 2009;49:566–70.

    Article  CAS  PubMed  Google Scholar 

  46. Dimitrov G, Gottrand F. Does gastric atrophy exist in children? World J Gastroenterol. 2006;12:6274–9.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol. 2010;16:5181–94.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Kalach N, Bontems P, Koletzko S, et al. Frequency and risk factors of gastric and duodenal ulcers or erosions in children: a prospective 1-month European multicenter study. Eur J Gastroenterol Hepatol. 2010;22:1174–81.

    Article  PubMed  Google Scholar 

  49. Riddell RH. Pathobiology of Helicobacter pylori infection in children. Can J Gastroenterol. 1999;13:599–603.

    Article  CAS  PubMed  Google Scholar 

  50. Graham DY, Yamaoka YH. H. Pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications. Helicobacter. 1998;3:145–51.

    Article  CAS  PubMed  Google Scholar 

  51. Levine A, Milo T, Broide E, et al. Influence of Helicobacter pylori eradication on gastroesophageal reflux symptoms and epigastric pain in children and adolescents. Pediatrics. 2004;113:54–8.

    Article  PubMed  Google Scholar 

  52. Iijima K, Koike T, Shimosegawa T. Reflux esophagitis triggered after Helicobacter pylori eradication: a noteworthy demerit of eradication therapy among the Japanese? Front Microbiol. 2015;6:566.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Pollet S, Gottrand F, Vincent P, et al. Gastroesophageal reflux disease and Helicobacter pylori infection in neurologically impaired children: inter-relations and therapeutic implications. J Pediatr Gastroenterol Nutr. 2004;38:70–4.

    Article  PubMed  Google Scholar 

  54. Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and Helicobacter pylori: what may be the relationship? J Neurogastroenterol Motil. 2010;16:243–50.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut. 2001;49:330–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Grande M, Cadeddu F, Villa M, et al. Helicobacter pylori and gastroesophageal reflux disease. World J Surg Oncol. 2008;6:74.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Ishiki K, Mizuno M, Take S, et al. Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol. 2004;2:474–9.

    Article  PubMed  Google Scholar 

  58. Hamada H, Haruma K, Mihara M, et al. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther. 2000;14:729–35.

    Article  CAS  PubMed  Google Scholar 

  59. Souza RF. From reflux esophagitis to esophageal adenocarcinoma. Dig Dis. 2016;34:483–90.

    Article  PubMed  Google Scholar 

  60. Asaka M, Kato M, Takahashi S, et al. Japanese Society for Helicobacter Research. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1–20.

    Article  CAS  PubMed  Google Scholar 

  61. Fischbach LA, Graham DY, Kramer JR, et al. Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol. 2014;109:357–68.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Kandulski A, Malfertheiner P. Helicobacter pylori and gastroesophageal reflux disease. Curr Opin Gastroenterol. 2014;30(4):402–7.

    Article  CAS  PubMed  Google Scholar 

  63. Rubenstein JH, Inadomi JM, Scheiman J, et al. Association between Helicobacter pylori and Barrett's esophagus, erosive esophagitis, and gastroesophageal reflux symptoms. Clin Gastroenterol Hepatol. 2014;12(2):239–45.

    Article  PubMed  Google Scholar 

  64. Ricuarte O, Gutierrez O, Cardona H, Kim JG, Graham DY, El-Zimaity HM. Atrophic gastritis in young children and adolescents. J Clin Pathol. 2005;58:1189–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Di Mario F, Goni E. Gastric acid secretion: changes during a century. Best Pract Res Clin Gastroenterol. 2014;28:953–65.

    Article  PubMed  Google Scholar 

  66. George S, Lucero Y, Torres JP, Lagomarcino AJ, O'Ryan M. Gastric damage and cancer-associated biomarkers in helicobacter pylori-infected children. Front Microbiol. 2020;11:90.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Lopes AI, Palha A, Lopes T, Monteiro L, Oleastro M, Fernandes A. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population. Scand J Gastroenterol. 2006;41:524–31.

    Article  PubMed  CAS  Google Scholar 

  68. Plonka M, Bielanski W, Konturek SJ, et al. Helicobacter pylori infection and serum gastrin, ghrelin and leptin in children of polish shepherds. Dig Liver Dis. 2006;38:91–7.

    CAS  PubMed  Google Scholar 

  69. Monkemuller K, Neumann H, Nocon M, et al. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study. Aliment Pharmacol Ther. 2008;15:491–6.

    Article  CAS  Google Scholar 

  70. Peitz U, Wex T, Vieth M, et al. Correlation of serum pepsinogens and gastrin-17 with atrophic gastritis in gastroesophageal reflux patients: a matched-pairs study. J Gastroenterol Hepatol. 2011;26:82–9.

    Article  PubMed  Google Scholar 

  71. Kim N, Jung HC. The role of serum pepsinogen in the detection of gastric cancer. Gut Liver. 2010;4:307–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Kassem E, Naamna M, Mawassy K, Beer-Davidson G, Muhsen K. Helicobacter pylori infection, serum pepsinogens, and pediatric abdominal pain: a pilot study. Eur J Pediatr. 2017;176:1099–105.

    Article  CAS  PubMed  Google Scholar 

  73. Nakayama Y, Lin Y, Hongo M, Hidaka H, Kikuchi S. Helicobacter pylori infection and its related factors in junior high school students in Nagano prefecture. Japan Helicobacter. 2017;22:e12363.

    Article  CAS  Google Scholar 

  74. De Angelis GL, Cavallaro LG, Maffini V, et al. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children. Dig Dis. 2007;25:206–13.

    Article  PubMed  Google Scholar 

  75. Nwokolo CU, Freshwater DA, O’Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut. 2003;52:637–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Arosio M, Ronchi CL, Gebbia C, Cappiello V, Beck-Peccoz P, Peracchi M. Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels. J Clin Endocrinol Metab. 2003;88:701–4.

    Article  CAS  PubMed  Google Scholar 

  77. Akamizu T, Kangawa K. Translational research on the clinical applications of ghrelin. Endocr J. 2006;53:585–91.

    Article  CAS  PubMed  Google Scholar 

  78. Williams DL, Cummings DE. Regulation of ghrelin in physiologic and pathophysiologic states. J Nutr. 2005;135:1320–5.

    Article  CAS  PubMed  Google Scholar 

  79. Chen CY, Asakawa A, Fujimiya M, Lee SD, Inui A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol Rev. 2009;61:430–81.

    Article  CAS  PubMed  Google Scholar 

  80. Takeshita E, Matsuura B, Dong M, Miller LJ, Matsui H, Onji M. Molecular characterization and distribution of motilin family receptors in the human gastrointestinal tract. J Gastroenterol. 2006;41:223–30.

    Article  CAS  PubMed  Google Scholar 

  81. Deng ZH, Chu B, Xu YZ, Zhang B, Jiang LR. Influence of Helicobacter pylori infection on ghrelin levels in children. World J Gastroenterol. 2012;18:5096–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Cindoruk M, Yetkin I, Deger SM, Karakan T, Kan E, Unal S. Influence of H pylori on plasma ghrelin in patients without atrophic gastritis. World J Gastroenterol. 2007;13:1595–159821.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol. 2008;14:6327–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Osawa H, Nakazato M, Date Y, et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab. 2005;90:10–6.

    Article  CAS  PubMed  Google Scholar 

  85. Isomoto H, Ueno H, Nishi Y, et al. Circulating ghrelin levels in patients with various upper gastrointestinal diseases. Dig Dis Sci. 2005;50:833–8.

    Article  CAS  PubMed  Google Scholar 

  86. Pacifico L, Anania C, Osborn JF, et al. Long-term effects of Helicobacter pylori eradication on circulating ghrelin and leptin concentrations and body composition in prepubertal children. Eur J Endocrinol. 2008;158:323–32.

    Article  CAS  PubMed  Google Scholar 

  87. Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins (Basel). 2019;11:677.

    Article  CAS  Google Scholar 

  88. Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22:e12405.

    Article  CAS  Google Scholar 

  89. Altomare A, Guarino MPL, Cocca S, Emerenziani S, Cicala M. Gastroesophageal reflux disease: update on inflammation and symptom perception. World J Gastroenterol. 2013;19:6523–8.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Luzza F, Pensabene L, Imeneo M, et al. Antral nodularity and positive CagA serology are distinct and relevant markers of severe gastric inflammation in children with Helicobacterpylori infection. Helicobacter. 2002;7(1):46–52.

    Article  PubMed  Google Scholar 

  91. Shavalipour A, Malekpour H, Dabiri H, Kazemian H, Zojaji H, Bahroudi M. Prevalence of cytotoxin-associated genes of Helicobacter pylori among Iranian GERD patients. Gastroenterol Hepatol Bed Bench. 2017;10:178–83.

    PubMed  PubMed Central  Google Scholar 

  92. Azuma T, Yamazaki S, Yamakawa A, et al. Association between diversity in the Src homology 2 domain—containing tyrosine phosphatase binding site of Helicobacter pylori CagA protein and gastric atrophy and cancer. J Infect Dis. 2004;189:820–7.

    Article  CAS  PubMed  Google Scholar 

  93. Ghoshal UC, Tiwari S, Dhingra S, et al. Frequency of Helicobacter pylori and CagA antibody in patients with gastric neoplasms and controls: the Indian enigma. Dig Dis Sci. 2008;53:1215–22.

    Article  PubMed  Google Scholar 

  94. Chiba H, Gunji T, Sato H, et al. A cross-sectional study on the risk factors for erosive esophagitis in young adults. Intern Med. 2012;51:1293–9.

    Article  PubMed  Google Scholar 

  95. Nejati S, Karkhah A, Darvish H, Validi M, Ebarhimpour S, Nouri HR. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders. Microb Pathog. 2018;117:43–8.

    Article  CAS  PubMed  Google Scholar 

  96. de Brito BB, da Silva FAF, Soares AS, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019;25(37):5578–89.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  97. Daugule I, Rumba I, Engstrand L, Ejderhamn J. Infection with cagA-positive and cagA-negative types of Helicobacter pylori among children and adolescents with gastrointestinal symptoms in Latvia. Eur J Clin Microbiol Infect Dis. 2003;22:622–4.

    CAS  PubMed  Google Scholar 

  98. Vorobjova T, Grünberg H, Oona M, et al. Seropositivity to Helicobacter pylori and CagA protein in schoolchildren of different ages living in urban and rural areas in southern Estonia. Eur J Gastroenterol Hepatol. 2000;12:97–101.

    Article  CAS  PubMed  Google Scholar 

  99. Mourad-Baars P, Hussey S, Jones NL. Helicobacter pylori infection and childhood. Helicobacter. 2010;15:53–9.

    Article  PubMed  Google Scholar 

  100. Sharma P, Vakil N. Helicobacter pylori and reflux disease. Aliment Pharmacol Ther. 2003;17:287–305.

    Article  Google Scholar 

  101. Sabbagh P, Mohammadnia-Afrouzi M, Javanian M, et al. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations. Eur J Clin Microbiol Infect Dis. 2019;38:55–66.

    Article  CAS  PubMed  Google Scholar 

  102. Sokucu S, Ozden AT, Suoglu OD, et al. CagA positivity and its association with gastroduodenal disease in Turkish children undergoing endoscopic investigation. J Gastroenterol. 2006;41:533–9.

    Article  CAS  PubMed  Google Scholar 

  103. Selimoglu MA, Karabiber H, Otlu B, Yildirim O, Özer A, Samdanci E. Correlation of clinical, endoscopic, and histological findings with virulence factors in children with Helicobacter pylori gastritis. Eur J Gastroenterol Hepatol. 2014;26(6):602–6.

    Article  PubMed  Google Scholar 

  104. Alam J, Sarkar A, Karmakar BC, Ganguly M, Paul S, Mukhopadhyay AK. Novel virulence factor dupA of Helicobacter pylori as an important risk determinant for disease manifestation: an overview. World J Gastroenterol. 2020;26:4739–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. Ansari S, Yamaoka Y. Helicobacter pylori BabA in adaptation for gastric colonization. World J Gastroenterol. 2017;23(23):4158–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol. 2017;23:1521–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Kütükcüler N, Aydogdu S, Göksen D, Caglayan S, Yagcyi RV. Increased mucosal inflammatory cytokines in children with Helicobacter pylori-associated gastritis. Acta Paediatr. 1997;86:928–31.

    Article  PubMed  Google Scholar 

  108. Llorca L, Pérez-Pérez G, Urruzuno P, et al. Characterization of the gastric microbiota in a pediatric population according to Helicobacter pylori status. Pediatr Infect Dis J. 2017;36:173–8.

    Article  PubMed  Google Scholar 

  109. Brawner KM, Kumar R, Serrano CA, et al. Helicobacter pylori infection is associated with an altered gastric microbiota in children. Mucosal Immunol. 2017;10:1169–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Bravo D, Hoare A, Soto C, Valenzuela MA, Quest AF. Helicobacter pylori in human health and disease: mechanisms for local gastric and systemic effects. World J Gastroenterol. 2018;24:3071–89.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  111. Maldonado-Contreras A, Goldfarb KC, Godoy-Vitorino F, et al. Structure of the human gastric bacterial community in relation to Helicobacter pylori status. ISME J. 2011;5:574–9.

    Article  CAS  PubMed  Google Scholar 

  112. Thorell K, Yahara K, Berthenet E, et al. Correction: rapid evolution of distinct Helicobacter pylori subpopulations in the Americas. PLoS Genet. 2017;13:e1006730.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Kato S, Fujimura S, Kimura K, et al. Non-Helicobacter bacterial flora rarely develops in the gastric mucosal layer of children. Dig Dis Sci. 2006;51:641–6.

    Article  PubMed  Google Scholar 

  114. Fang HR, Zhang GQ, Cheng JY, et al. Efficacy of lactobacillus-supplemented triple therapy for Helicobacter pylori infection in children: a meta-analysis of randomized controlled trials. Eur J Pediatr. 2019;178:7–16.

    Article  CAS  PubMed  Google Scholar 

  115. Feng J-R, Wang F, Qiu X, et al. Efficacy and safety of probiotic supplemented triple therapy for eradication of Helicobacter pylori in children: a systematic review and network meta-analysis. Eur J Clin Pharmacol. 2017;73:1199–208.

    Article  PubMed  Google Scholar 

Download references

Financial Support

None.

Conflict-of-Interest

None.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yücel, O. (2022). GER and Helicobacter pylori. In: Vandenplas, Y. (eds) Gastroesophageal Reflux in Children. Springer, Cham. https://doi.org/10.1007/978-3-030-99067-1_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-99067-1_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-99066-4

  • Online ISBN: 978-3-030-99067-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics